Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PHAR is expected to report earnings to fall 94.32% to -1 cents per share on July 31
Q2'25
Est.
$-0.01
Q1'25
Missed
by $0.21
Q4'24
Beat
by $0.07
Q3'24
Missed
by $0.02
Q2'24
Missed
by $0.02
The last earnings report on May 08 showed earnings per share of -21 cents, missing the estimate of 0 cents. With 1.29K shares outstanding, the current market capitalization sits at 726.47M.